申请人:Sanofi
公开号:US20140206608A1
公开(公告)日:2014-07-24
The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.